Dilworth, David http://orcid.org/0000-0001-5557-9476
Hanley, Ronan P.
Ferreira de Freitas, Renato
Allali-Hassani, Abdellah
Zhou, Mengqi
Mehta, Naimee
Marunde, Matthew R.
Ackloo, Suzanne
Carvalho Machado, Raquel Arminda http://orcid.org/0000-0001-5912-2991
Khalili Yazdi, Aliakbar
Owens, Dominic D. G.
Vu, Victoria
Nie, David Y.
Alqazzaz, Mona
Marcon, Edyta
Li, Fengling
Chau, Irene
Bolotokova, Albina
Qin, Su
Lei, Ming
Liu, Yanli
Szewczyk, Magdalena M.
Dong, Aiping
Kazemzadeh, Sina
Abramyan, Tigran
Popova, Irina K.
Hall, Nathan W.
Meiners, Matthew J.
Cheek, Marcus A.
Gibson, Elisa http://orcid.org/0000-0002-7112-337X
Kireev, Dmitri http://orcid.org/0000-0001-8479-8555
Greenblatt, Jack F.
Keogh, Michael-C. http://orcid.org/0000-0002-2219-8623
Min, Jinrong http://orcid.org/0000-0001-5210-3130
Brown, Peter J. http://orcid.org/0000-0002-8454-0367
Vedadi, Masoud http://orcid.org/0000-0002-0574-0169
Arrowsmith, Cheryl H. http://orcid.org/0000-0002-4971-3250
Barsyte-Lovejoy, Dalia http://orcid.org/0000-0002-6560-9621
James, Lindsey I. http://orcid.org/0000-0002-6034-7116
Schapira, Matthieu http://orcid.org/0000-0002-1047-3309
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R44GM117683, R44GM116584)
Cancer Research Society (25418, 25418)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA242305, R01CA242305)
Ontario Genomics Institute (OGI-196)
Innovative Medicines Initiative (875510)
Wellcome Trust (106169/ZZ14/Z)
Article History
Received: 10 July 2020
Accepted: 9 September 2021
First Online: 15 November 2021
Competing interests
: M.R.M., I.K.P., N.W.H., M.J.M., M.A.C. and M.-C.K. are employees of EpiCypher, a commercial developer and supplier of reagents and platforms used in this study: recombinant semi-synthetic dNucs and the dCypher binding assay. The remaining authors declare no competing interests.